<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3E582C47-2614-4CAC-9585-132613D58E85"><gtr:id>3E582C47-2614-4CAC-9585-132613D58E85</gtr:id><gtr:name>Celladon</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F31D4A66-92AA-4002-BD5A-B0E539ACF08F"><gtr:id>F31D4A66-92AA-4002-BD5A-B0E539ACF08F</gtr:id><gtr:name>Mount Sinai Hospital (USA)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3E582C47-2614-4CAC-9585-132613D58E85"><gtr:id>3E582C47-2614-4CAC-9585-132613D58E85</gtr:id><gtr:name>Celladon</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F31D4A66-92AA-4002-BD5A-B0E539ACF08F"><gtr:id>F31D4A66-92AA-4002-BD5A-B0E539ACF08F</gtr:id><gtr:name>Mount Sinai Hospital (USA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/240A7771-ACF9-404B-B9C9-FDDDBC58F050"><gtr:id>240A7771-ACF9-404B-B9C9-FDDDBC58F050</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:surname>Lyon</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500373"><gtr:id>E9ADDDAD-87C8-4E3E-80F9-17F9ED4AE6D5</gtr:id><gtr:title>Models for assessment of arrhythmogenicity after gene or cell transfer</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0500373</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>138219</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mount Sinai Hospital (USA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Gene therapy collaboration</gtr:description><gtr:id>D6BF67E4-9A80-474E-B0A2-78A177588FC7</gtr:id><gtr:impact>Two papers currently under review
One paper Published
One manuscript in preparation</gtr:impact><gtr:outcomeId>B3FBE15A9CC-1</gtr:outcomeId><gtr:partnerContribution>Gift of state-of-the-art gene therapy vectors for cardiac gene transfer studies.</gtr:partnerContribution><gtr:piContribution>Novel studies of cardiomyocytes after cardiac gene transfer.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Servier Laboratories</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Investigation of ryanodine receptor stabiliser pharmacology</gtr:description><gtr:id>BF211367-C90C-4DAD-B848-9859588FC4CC</gtr:id><gtr:impact>Full report

Awaiting scientific publication</gtr:impact><gtr:outcomeId>EBQQeJfA1rH-1</gtr:outcomeId><gtr:partnerContribution>Drug supply and financial support</gtr:partnerContribution><gtr:piContribution>Assessment in in vivo heart failure models and in vitro cell studies</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Celladon</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>SERCA-LVAD trial</gtr:description><gtr:id>DE206921-9A23-41A2-A57D-8CA4CBF64F83</gtr:id><gtr:impact>European leading recruitment centre for CUPID2 trial</gtr:impact><gtr:outcomeId>54613ef74ad255.95862725-1</gtr:outcomeId><gtr:partnerContribution>Finanical
Delivery and provision of 24 doses of SERCA2a gene therapy or placebo
24 month salary for research nurse</gtr:partnerContribution><gtr:piContribution>PI for the SERCA-LVAD Gene Therapy Trial

ClinicalTrials.gov Identifier: NCT00534703; EudraCT : 2007-002809-48</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Celladon</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Consultant to international phase 2b gene therapy trial</gtr:description><gtr:id>624D8382-237E-424D-8E5F-7DE953942301</gtr:id><gtr:impact>Starting Phase 2b SERCA2a gene therapy trial in Heart failure patients in the UK</gtr:impact><gtr:outcomeId>ifdGnhNESVu-1</gtr:outcomeId><gtr:partnerContribution>Sponsor of trial</gtr:partnerContribution><gtr:piContribution>International consultant to Celladon
Advice re design and management of clinical gene therapy trial
UK National Coordinating Investigator for the CUPID2 trial.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk to Friends of the Royal Brompton Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5E1A7BA7-F6CD-4214-9015-D1789E82E0D1</gtr:id><gtr:impact>Talk to ~30 members of the public who are part of the 'Friends of the Royal brompton Hospital' support group.

Positive feedback from the meeting chair.</gtr:impact><gtr:outcomeId>ki9P1pLoSR7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe Scientifique</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B6CBF723-CAC7-4EBB-9340-20AAF21CBAD8</gtr:id><gtr:impact>Q+A from an audience of 70 members fo the public following a 5-10 minute oral presentation, chaired by professor Richard Ashcroft.

House of Lords interest and approached me to participate in an advisory panel; patient recruitment into the gene therapy trial; local students interested for their projects and work experience.</gtr:impact><gtr:outcomeId>ZN5p6rT8eXN</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recorded interview for the BBC National news</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F085797C-D774-4EA6-9925-493A896F8048</gtr:id><gtr:impact>Recorded piece with Fergus Walsh for the National BBC six and ten o'clock news

Public interest and feedback</gtr:impact><gtr:outcomeId>hFWkNEik2u6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-23962607</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview for the Today programme</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>47964D4A-1060-4E7A-B83F-A0EDAD7C4221</gtr:id><gtr:impact>Recorded interview for the Today programme regarding Gene therapy trial.

Public interest in the trial and BHF funding.</gtr:impact><gtr:outcomeId>UQRVtviw9FH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial College Outreach Programme for Local Schools</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B73E3B47-7E85-4925-BF1E-B85B4357A43D</gtr:id><gtr:impact>Hosted sixth form students from local schools to offer them an insight into medical research and medical careers.

I have been contacted by several of the participants for further advice regarding applications to medical school and/or university for biological sciences.</gtr:impact><gtr:outcomeId>382F27691A2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News article for Sky News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>685325EB-B5A2-48E2-93EB-48A7B90D9E88</gtr:id><gtr:impact>Recorded news piece on cardiac gene therapy for the Sky news

Public interest and feedback</gtr:impact><gtr:outcomeId>XwifeuznxmP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://news.sky.com/story/1084769/heart-failure-first-uk-gene-therapy-trial</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recorded radio interview for Today programme</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E3C0C372-98E0-4903-817D-988261DB685C</gtr:id><gtr:impact>Recorded interview for the Today programme regarding the SERCA2a gene therapy trial

Public feedback and interest</gtr:impact><gtr:outcomeId>GazM4aNzq35</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Channel 4 News piece</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>16DCBAC5-5F5C-4FFE-B0E0-3BB56752D14B</gtr:id><gtr:impact>Recorded news piece on cardiac gene therapy for the Channel 4 news

Public interest</gtr:impact><gtr:outcomeId>i1CWushncPv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.channel4.com/news/gene-therapy-hope-for-heart-failure-patients</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Newspaper Coverage</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7E4F4991-CB18-4260-9BAC-0A4043D0B52B</gtr:id><gtr:impact>Front page of Daily Telegraph - coverage of our new gene therapy trial

Contact from media organisations and patients</gtr:impact><gtr:outcomeId>546149af11be10.78123709</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.telegraph.co.uk/health/healthnews/11027207/Pioneering-new-injection-to-cure-heart-failure-without-need-for-major-surgery.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>174085</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collaboration with Celladon</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Celladon</gtr:fundingOrg><gtr:id>3B6248DC-FA70-4205-9472-0A53776FF6B1</gtr:id><gtr:outcomeId>56e05431512a10.76410134</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>315000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Special Programme Award</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>9A8735CA-39F6-49C7-8F06-3FE159765306</gtr:id><gtr:outcomeId>gGYTSywcFuz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welcome Trust Clinical PhD Fellowship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>AC5F27A7-56AD-456E-A9F8-B60DDD3A0F45</gtr:id><gtr:outcomeId>m4fW3BwHMDV0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HFA Nursing Fellowship</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Society of Cardiology (ESC)</gtr:fundingOrg><gtr:id>9AE5586E-1BFC-48B8-9E81-BFC5C0450EE0</gtr:id><gtr:outcomeId>54614245a88d25.86578460</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>819930</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Intermediate Clinical Research Fellowship</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>3FDA66B3-F9B2-440F-B922-129CA197E47A</gtr:id><gtr:outcomeId>ez1mwoaeoU30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AMS, Clinical Lecturer Starter Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>47D4BB75-80EF-4987-8130-242BEBEF5365</gtr:id><gtr:outcomeId>3E0FD7C84A00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>SERCA2a gene therapy trial - completed recruitment, currently in active follow up phase</gtr:description><gtr:id>EB2ABF8D-B719-47CF-9315-6E693191483A</gtr:id><gtr:impact>We are Europe's leading recruitment centre for the international CUPID2 trial, and I have been invited to lead the arrhythmia substudy.</gtr:impact><gtr:outcomeId>54614fe38b5dc5.28390377</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>SERCA2a Gene Therapy</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Started recruitment of SERCA-LVAD Trial:
Investigation of the safety and efficacy of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist device: The SERCA-LVAD trial (ClinicalTrials.gov Identifier: NCT00534703; EudraCT : 2007-002809-48).</gtr:description><gtr:id>CC1712BD-AA54-491F-9696-5FCF3E4C999F</gtr:id><gtr:impact>World's first clinical trial of gene therapy in this patient group (adults with LVADs fro chronic heart failure)</gtr:impact><gtr:outcomeId>54614ecc02ded3.81911092</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>SERCA2a gene therapy</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F5AC4383-68D9-4C63-9B23-5C99E4EA7EDA</gtr:id><gtr:title>Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Cardiovascular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1743-4297</gtr:issn><gtr:outcomeId>256D7F949E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB53E996-1094-4DEF-A480-9B728E76A210</gtr:id><gtr:title>Gene Therapy in Heart Failure</gtr:title><gtr:parentPublicationTitle>Circulation Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20b1421747b5c7f185042836133c070b"><gtr:id>20b1421747b5c7f185042836133c070b</gtr:id><gtr:otherNames>Hayward C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5a6eee40b6e5b3.18146682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C022DAF-601A-4C46-B63B-4A48306D12B8</gtr:id><gtr:title>SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afa428fa986d1aed22307bf44eb7d516"><gtr:id>afa428fa986d1aed22307bf44eb7d516</gtr:id><gtr:otherNames>Sikkel MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14044_24_24138023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD98C990-7677-4730-9143-39F8E659B95B</gtr:id><gtr:title>Gene therapy: targeting the myocardium.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>D4C241F3066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91C6AABD-3F2C-4806-9401-EB6F2C66B201</gtr:id><gtr:title>Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a5c7901b9dbb3abef86f373fdc6bd2a"><gtr:id>1a5c7901b9dbb3abef86f373fdc6bd2a</gtr:id><gtr:otherNames>Wright PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>5461377c0dc9f7.25660994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3102EBC0-B113-41C4-81D8-E78DF872C6A1</gtr:id><gtr:title>Altered spatiotemporal dynamics of the mitochondrial membrane potential in the hypertrophied heart.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0135a8ecf8670d81314c9c4f1bc84df9"><gtr:id>0135a8ecf8670d81314c9c4f1bc84df9</gtr:id><gtr:otherNames>Jin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>585d5910e34d13.08585750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ED3C459-6339-40DD-B246-A79F3E8340B9</gtr:id><gtr:title>A commentary on clinical trials in chronic heart failure.</gtr:title><gtr:parentPublicationTitle>Seminars in cardiothoracic and vascular anesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e8277f06123284196922a82f2b0d8e"><gtr:id>63e8277f06123284196922a82f2b0d8e</gtr:id><gtr:otherNames>Poole-Wilson PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1089-2532</gtr:issn><gtr:outcomeId>54613ac719b3b4.51921668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA15DA8F-6A13-46F8-B267-DFADC7134F5E</gtr:id><gtr:title>Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b01194866d1a37f5b2c5cbc617ffd78"><gtr:id>4b01194866d1a37f5b2c5cbc617ffd78</gtr:id><gtr:otherNames>Nikolaev VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_14044_24_20185685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D641AA2-B69D-40FB-9DE9-374A7389A304</gtr:id><gtr:title>Arrhythmia mechanisms in the failing heart.</gtr:title><gtr:parentPublicationTitle>Pacing and clinical electrophysiology : PACE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0135a8ecf8670d81314c9c4f1bc84df9"><gtr:id>0135a8ecf8670d81314c9c4f1bc84df9</gtr:id><gtr:otherNames>Jin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0147-8389</gtr:issn><gtr:outcomeId>54613ac76e6cf1.00608502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>242F38C3-13E7-41E3-80F8-989E2106BA0F</gtr:id><gtr:title>Gene therapy in heart failure. SERCA2a as a therapeutic target.</gtr:title><gtr:parentPublicationTitle>Circulation journal : official journal of the Japanese Circulation Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20b1421747b5c7f185042836133c070b"><gtr:id>20b1421747b5c7f185042836133c070b</gtr:id><gtr:otherNames>Hayward C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1346-9843</gtr:issn><gtr:outcomeId>546136c5317cf1.37056634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60245917-40B5-403E-955E-9E856563FAAB</gtr:id><gtr:title>Mind the store: modulating Ca(2+) reuptake with a leaky sarcoplasmic reticulum.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9bf240b3fa8d3946efbf97b070e8a22"><gtr:id>c9bf240b3fa8d3946efbf97b070e8a22</gtr:id><gtr:otherNames>Louch WE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>pm_14044_24_23524302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD7419F4-0A2F-4C88-AE85-57B853E8B045</gtr:id><gtr:title>SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.</gtr:title><gtr:parentPublicationTitle>Circulation. Arrhythmia and electrophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1941-3084</gtr:issn><gtr:outcomeId>faDbN1epf3G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9321ECD-677D-4F37-B9E4-F6DC84C36775</gtr:id><gtr:title>Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cb695c06672f78bc5c58ceda122406b"><gtr:id>4cb695c06672f78bc5c58ceda122406b</gtr:id><gtr:otherNames>Hajjar RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5461377ca8d824.78274230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DC4DCB4-4DFD-4320-BDCC-3D62F0AC5A28</gtr:id><gtr:title>Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06243e2f5986af4aa2b31b97b30ec4cf"><gtr:id>06243e2f5986af4aa2b31b97b30ec4cf</gtr:id><gtr:otherNames>Chahine MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>546136c508ffc5.50296346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E262C4A-A44F-41E9-813C-7396AA11B279</gtr:id><gtr:title>Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn><gtr:outcomeId>54613ac794cce5.02498896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEEE6D20-51E0-40C9-A911-AE85BF7D66D8</gtr:id><gtr:title>Plasticity of surface structures and ?(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure.</gtr:title><gtr:parentPublicationTitle>Circulation. Heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1941-3289</gtr:issn><gtr:outcomeId>pm_14044_24_22456061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>060CEF2F-DBBC-44C5-9672-D1DB192FBAC8</gtr:id><gtr:title>Spatial control of the ?AR system in heart failure: the transverse tubule and beyond.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4685265a0f29d6350e4c6396a8e5f1ee"><gtr:id>4685265a0f29d6350e4c6396a8e5f1ee</gtr:id><gtr:otherNames>Gorelik J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>pm_14044_24_23345264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EBE5A16-14A8-4F02-9595-0698618FC618</gtr:id><gtr:title>SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2408d5c1b131b88e5d5d5a8c95ab565"><gtr:id>a2408d5c1b131b88e5d5d5a8c95ab565</gtr:id><gtr:otherNames>Kumarswamy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>pm_14044_24_22362515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F2B0C5E-ACBE-4124-B1FB-7AAAF74ECC72</gtr:id><gtr:title>The potential of cardiac stem cell therapy for heart failure.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/967fd2b129c1663062568ccd5c916b62"><gtr:id>967fd2b129c1663062568ccd5c916b62</gtr:id><gtr:otherNames>Lyon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>5753564A441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D75613EA-E13B-4C24-8315-051522B6A13D</gtr:id><gtr:title>Optical imaging of mitochondrial function uncovers actively propagating waves of mitochondrial membrane potential collapse across intact heart.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>54613ac843b667.28418922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44E830FF-63F0-46AB-9C02-9464F7A85684</gtr:id><gtr:title>Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5af33e2fd93b341985c0f1d72330c9"><gtr:id>fd5af33e2fd93b341985c0f1d72330c9</gtr:id><gtr:otherNames>Lyon AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>00D0A2DCE84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57165070-D71B-4FA2-83D2-18D34C8EDBA3</gtr:id><gtr:title>Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bfe855d3c7ade9562324f354426e17"><gtr:id>c5bfe855d3c7ade9562324f354426e17</gtr:id><gtr:otherNames>Park JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5461377d2ae0f7.98329046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C82DB77-3ABC-4217-A01B-12793EDE9EAA</gtr:id><gtr:title>An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56e2ad701f4e6e6b941562cdf68a5c31"><gtr:id>56e2ad701f4e6e6b941562cdf68a5c31</gtr:id><gtr:otherNames>Chen QZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>54613ac7e0de85.03824671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FC5AB36-CA2C-42B7-82E5-9DEC083F1145</gtr:id><gtr:title>Myocardial tissue engineering.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3583a3ad130a65ddb78ebd0a11a6fde9"><gtr:id>3583a3ad130a65ddb78ebd0a11a6fde9</gtr:id><gtr:otherNames>Jawad H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>54613ac7bc9875.63791000</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500373</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>